Skip to content


Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at), or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

| Press release
Fresenius Medical Care confirms outlook for 2021 while considering the continued negative impact of COVID-19
Stronger than projected headwind from COVID-19 effects with significantly increased patient excess mortality due to global spread of Delta variant
| Press release
Fresenius Medical Care transforms its operating model, entering the next phase of its 2025 growth strategy
Fresenius Medical Care continues to execute on its growth strategy 2025 launched in October 2020.
| Press release
Fresenius Medical Care increases investment in Humacyte, accompanies human acellular vessel developer’s stock market launch
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is investing an additional USD 25 million in the U.S. medical company Humacyte, Inc.
| Short News
Fresenius Medical Care opens new facility for laboratory services
Fresenius Medical Care North America opens a new laboratory in Mississippi, USA. With 200,000-square-foot (19,000 square-meters), it is the company’s largest facility of this kind.
1 2 3 4 ... 23
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.